HAG
HighPoint Advisor Group’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-907
| Closed | -$222K | – | 708 |
|
|
2024
Q2 | $222K | Sell |
907
-47
| -5% | -$11.5K | 0.01% | 556 |
|
|
2024
Q1 | $218K | Sell |
954
-18
| -2% | -$4.11K | 0.02% | 579 |
|
|
2023
Q4 | $258K | Buy |
+972
| New | +$258K | 0.02% | 514 |
|
|
2022
Q2 | $320K | Buy |
+1,416
| New | +$320K | 0.04% | 386 |
|
|
2021
Q3 | $955K | Buy |
2,314
+87
| +4% | +$35.9K | 0.09% | 177 |
|
|
2021
Q2 | $824K | Buy |
2,227
+67
| +3% | +$24.8K | 0.08% | 203 |
|
|
2021
Q1 | $662K | Sell |
2,160
-156
| -7% | -$47.8K | 0.08% | 214 |
|
|
2020
Q4 | $644K | Buy |
2,316
+1,015
| +78% | +$282K | 0.08% | 204 |
|
|
2020
Q3 | $327K | Sell |
1,301
-409
| -24% | -$103K | 0.06% | 256 |
|
|
2020
Q2 | $300K | Sell |
1,710
-254
| -13% | -$44.6K | 0.06% | 244 |
|
|
2020
Q1 | $268K | Buy |
+1,964
| New | +$268K | 0.06% | 232 |
|
|
2019
Q4 | – | Sell |
-887
| Closed | -$115K | – | 392 |
|
|
2019
Q3 | $115K | Buy |
887
+104
| +13% | +$13.5K | 0.03% | 438 |
|
|
2019
Q2 | $106K | Buy |
+783
| New | +$106K | 0.02% | 443 |
|
|
2017
Q4 | – | Sell |
-8,056
| Closed | -$944K | – | 302 |
|
|
2017
Q3 | $944K | Buy |
8,056
+2,643
| +49% | +$310K | 0.29% | 87 |
|
|
2017
Q2 | $539K | Hold |
5,413
| – | – | 0.17% | 148 |
|
|
2017
Q1 | $539K | Buy |
+5,413
| New | +$539K | 0.17% | 148 |
|